Skip to main content
. 2025 Aug 1;17(8):1009. doi: 10.3390/pharmaceutics17081009
SCC Squamous cell carcinoma
NMSCs Non-melanoma skin cancers
BCC Basal cell carcinoma
UV Ultraviolet
ROS Reactive oxygen species
RNS Reactive nitrogen species
HPV Human papillomavirus
AK Actinic keratosis
BD Bowen’s disease
SC Stratum corneum
EPR Enhanced permeability and retention effect
PDT Photodynamic therapy
5-FU 5-Fluorouracil
API Active pharmaceutical ingredient
DMSO Dimethylsulfoxide
SLNs Solid lipid nanoparticles
NLCs Nanostructured lipid carriers
AgNPs Silver nanoparticles
AuNPs Gold nanoparticles
STING Stimulator of Interferon Genes
BCS Biopharmaceutical classification system
IMQ Imiquimod
FDA United States Food and Drug Administration
EMA European Medicines Agency
ADP Adenosine diphosphate ribose
COX-2 Cyclooxygenase-2
PGE2 Prostaglandin E2
IM Ingenol mebutate
VD3A Vitamin D3 analogs
VDR Vitamin D receptor
RARs Retinoic acid receptors
RXRs Retinoid X receptors
CTCL Cutaneous T-cell lymphoma
STAT3 Signal Transducer and Activator of Transcription 3
siRNA Small interfering RNA